|
Mr. Clayton was elected to the board of directors in October 2005. Mr. Clayton joins Matrixx’s Board with over 30 years of research and development experience at Schering-Plough Healthcare Products, Inc. Most recently, Mr. Clayton served as the Senior Vice President of Scientific and Regulatory Affairs for Schering-Plough, a position he was appointed to in September 1984. In that position, Mr. Clayton was responsible for research and development of drugs and devices as well as regulatory affairs, clinical research, and prescription-to-over-the-counter drug switch programs. Prior to joining Schering-Plough in April 1974, Mr. Clayton held several research and teaching positions, which include serving as Associate Professor at the University of Tennessee as well as a Research Biologist at the Food and Drug Administration’s National Center for Toxicological Research. | 